ExodusPoint Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,483
| Closed | -$260K | – | 1797 |
|
|
2024
Q4 | $260K | Buy |
+15,483
| New | +$260K | ﹤0.01% | 1202 |
|
|
2023
Q1 | – | Sell |
-4,016
| Closed | -$60K | – | 1969 |
|
|
2022
Q4 | $60K | Sell |
4,016
-31,308
| -89% | -$468K | ﹤0.01% | 1487 |
|
|
2022
Q3 | $417K | Buy |
+35,324
| New | +$417K | 0.01% | 1398 |
|
|
2022
Q2 | – | Sell |
-41,877
| Closed | -$1.25M | – | 2296 |
|
|
2022
Q1 | $1.25M | Buy |
41,877
+5,650
| +16% | +$169K | 0.02% | 968 |
|
|
2021
Q4 | $960K | Buy |
36,227
+33,717
| +1,343% | +$893K | 0.01% | 1056 |
|
|
2021
Q3 | $91K | Buy |
+2,510
| New | +$91K | ﹤0.01% | 1862 |
|
|
2021
Q2 | – | Sell |
-2,647
| Closed | -$91K | – | 2650 |
|
|
2021
Q1 | $91K | Sell |
2,647
-321
| -11% | -$11K | ﹤0.01% | 1939 |
|
|
2020
Q4 | $104K | Sell |
2,968
-1,023
| -26% | -$35.8K | ﹤0.01% | 1754 |
|
|
2020
Q3 | $96K | Buy |
3,991
+1,681
| +73% | +$40.4K | ﹤0.01% | 1535 |
|
|
2020
Q2 | $42K | Buy |
+2,310
| New | +$42K | ﹤0.01% | 1665 |
|
|
2020
Q1 | – | Sell |
-1,112
| Closed | -$24K | – | 1497 |
|
|
2019
Q4 | $24K | Buy |
+1,112
| New | +$24K | ﹤0.01% | 1411 |
|
|
2019
Q3 | – | Sell |
-1,898
| Closed | -$50K | – | 1557 |
|
|
2019
Q2 | $50K | Buy |
+1,898
| New | +$50K | ﹤0.01% | 1026 |
|